2022-11-17 17:14:05 T AT&T
11/17/22 11/1717:14 11/17/2217:14 | AT&T sees elevated investment levels in 2022-2023, moderated spending in 2024CFO Pascal Desroches spoke today at the Morgan Stanley European Technology, Media & Telecom Conference where he provided an update to shareholders, stating: "The company has continued to add customers in its strategic focus areas of 5G and fiber as customer demand for connectivity services remains healthy. While the company continues to monitor the evolving economic backdrop, Desroches feels confident in the ongoing benefits of AT&T's simplified business model as a pure play connectivity provider. He believes AT&T's consistent go-to-market approach, along with an improved customer experience, continues to attract high-value customers. Desroches highlighted that the company is now lapping investments made over the past two years and realizing additional cost savings from its transformation initiatives to enhance its high-performing workforce, optimize and expand connectivity networks and improve distribution. Though the company remains vigilant around inflationary pressures impacting all elements of the economy, the benefits of its cost reduction measures are increasingly falling to the bottom line, as evidenced by AT&T's accelerating third quarter adjusted EBITDA growth. In addition, Desroches shared that he feels good about the resilient nature of AT&T's connectivity services, and that pricing actions are proving accretive and performing slightly better than anticipated. Desroches said that AT&T Fiber continues to deliver the best customer experience in the marketplace and he's pleased with the momentum in AT&T Fiber's ARPU and penetration rates for new fiber build. As AT&T expands to new markets, the company has seen AT&T Fiber first-year penetration rates about two times greater than historical norms. AT&T continues to expand its fiber footprint and has the ability to serve 18.5 million consumer locations and 3.0 million business locations in more than 100 metro areas with fiber. Desroches added that AT&T expects to achieve its target of 30 million-plus locations with fiber by the end of 2025. Additionally, AT&T is continuously exploring ways to expand where it can serve customers fiber, including outside of its traditional wireline service area. Desroches said that when AT&T Fiber is available, the company has also seen an uplift in subscriber penetration. Regardless of location, AT&T will target areas not currently widely served with fiber and that offer attractive returns. Fiber deployments also support AT&T's wireless business. Desroches shared that AT&T expects to invest at record levels this year to meet growing demand for core connectivity, while also meeting free cash flow guidance for the year in the $14 billion range and continuing to pay an attractive dividend. Desroches reiterated that AT&T expects elevated levels of capital investment in 2022 and 2023 with moderated investment beginning in 2024. The company remains focused on investing in building a sustainable and durable connectivity operation with improved cash generation and continues to be pleased with the return profile of its fiber and 5G investments. Desroches indicated that the company's long-term capital allocation priorities remain unchanged, 95% of the company's debt is fixed and that he continues to expect AT&T will use cash after dividends to reduce debt, with a goal of reducing net debt-to-adjusted EBITDA to the 2.5x range." |
|
---|
Periodicals
|
Danaher has expressed takeover interest in Catalent, Bloomberg says »
17:09 02/04/23 02/0417:09 02/04/2317:09
CTLT
Catalent
Danaher
Danaher (DHR) has… Story temporarily locked. ShowHide Related Items >><<
|
On The Fly
|
Short Report: Stitch Fix bears less skittish despite more sharp gains in stock »
13:06 02/04/23 02/0413:06 02/04/2313:06
SFIX
Stitch Fix
Janux Therapeutics
Silvergate Capital
Dutch Bros
Earthstone Energy
Welcome to this week’s… ShowHide Related Items >><<
|
Periodicals
|
Buy Ulta Beauty stock, a winner in good times and bad, Barron's says »
09:53 02/04/23 02/0409:53 02/04/2309:53
ULTA
Ulta Beauty
Ulta Beauty stock was a… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Tesla has rocketed, time to take some profits, Barron's says »
09:51 02/04/23 02/0409:51 02/04/2309:51
TSLA
Tesla
Tesla stock is on a tear,… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Housing downturn could fuel gains for residential REITs, Barron's says »
09:48 02/04/23 02/0409:48 02/04/2309:48
AVB
AvalonBay
Essex Property Trust
Camden Property
Equity Residential
Invitation Homes
After a really bad year,… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Linden investing big in hydrogen, time to buy stock, Barron's says »
09:44 02/04/23 02/0409:44 02/04/2309:44
LIN
Linde
The thunderous force of… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Pfizer stock a buy as company moves beyond COVID, Barron's says »
09:40 02/04/23 02/0409:40 02/04/2309:40
PFE
Pfizer
Pfizer's two COVID… Story temporarily locked. ShowHide Related Items >><<
|
On The Fly
|
Buy/Sell: Wall Street's top 10 stock calls this week »
09:29 02/04/23 02/0409:29 02/04/2309:29
META
Meta Platforms
Tesla
Shopify
Uber
DoorDash
Foot Locker
Kroger
Walmart
Albertsons
Paramount
Edwards Lifesciences
Fortune Brands Innovations
Ford
What has Wall Street been… ShowHide Related Items >><<
|
Hot Stocks
|
Takeda Pharmaceutical: FDA approves sBLA for expanded use of TAKHZYRO »
18:51 02/03/23 02/0318:51 02/03/2318:51
TAK
Takeda Pharmaceutical
Takeda announced that the… Takeda announced that the U.S. FDA has approved the supplemental Biologics License Application for the expanded use of TAKHZYRO for prophylaxis to prevent attacks of hereditary angioedema in pediatric patients 2 to less than12 years of age. Prior to this approval, the only approved routine prophylaxis treatment options for children 6 to less than12 years of age required dosing every three to four days, and children with HAE 2 to less than 6 years of age had no approved prophylaxis treatment, making TAKHZYRO the first prophylaxis treatment for this age group. The recommended dose is 150 mg/1 mL solution in a single-dose prefilled syringe every four weeks in patients 2 to less than 6 years of age and every two weeks in patients 6 to less than 12 years of age. ShowHide Related Items >><<
|
Hot Stocks
|
LGI Homes announced it closed 331 homes in January »
18:29 02/03/23 02/0318:29 02/03/2318:29
LGIH
LGI Homes
As of January 31, the… As of January 31, the company had 97 active selling communities. ShowHide Related Items >><<
|
Hot Stocks
|
Atento announces successful capital raise »
18:16 02/03/23 02/0318:16 02/03/2318:16
ATTO
Atento
Atento confirms that it… Atento confirms that it has secured its previously announced financing program. The additional capital raised will further strengthen Atento's balance sheet and liquidity position as management focuses on transforming the business. The fourth quarter has continued the positive trend by generating strong EBITDA margin growth, delivering the cash balance to close at $84M on December 31, 2022. ShowHide Related Items >><<
|
Hot Stocks
|
Sony delays 'The Last of Us Part I' PC port to March 28 »
18:07 02/03/23 02/0318:07 02/03/2318:07
SONY
Sony
Sony's Naughty Dog… Sony's Naughty Dog has delated the PC port of 2022 video game "The Last of Us Part I" to March 28 from March 3. The game, which is a remake of the 2013 game of the same name, originally launched in 2022 for PlayStation 5. Reference Link ShowHide Related Items >><<
|
Periodicals
|
Elon Musk prevails in shareholder lawsuit over 2018 tweet, WSJ says »
18:03 02/03/23 02/0318:03 02/03/2318:03
TSLA
Tesla
A jury rejected… A jury rejected shareholder claims that Elon Musk violated federal securities law when he tweeted in 2018 about potentially taking Tesla private, The Wall Street Journal's Rebecca Elliott reports. The nine-person jury said the investors who brought the class-action case failed to prove that Musk hurt them by tweeting about a possible deal. Reference Link ShowHide Related Items >><<
|
Hot Stocks
|
ArrowMark Financial Corp. reports estimated NAV $20.79 as of December 31 »
17:46 02/03/23 02/0317:46 02/03/2317:46
BANX
ArrowMark Financial Corp.
This NAV reflects the… This NAV reflects the regular fourth quarter dividend of 39c per share plus the special dividend of 10c per share. ShowHide Related Items >><<
|
Hot Stocks
|
BMW invests EUR800M in Mexican production site for electric vehicles »
17:31 02/03/23 02/0317:31 02/03/2317:31
BMWYY
BMW
The BMW Group is… The BMW Group is investing EUR800M in its Mexican production site in San Luis Potosi for the integration of fully electric models of NEUE KLASSE and construction of local high-voltage battery assembly. The company said that the move will lead to 1,000 new jobs at the San Luis Potosi factory and could mean that achieving 50% share of the company's worldwide sales of fully electric vehicles earlier than 2030. "We are systematically gearing our production network towards electromobility. In Mexico, we are investing 800 million euros in our plant and creating around 1,000 new jobs," explained Milan Nedeljkovi, member of the Board of Management of BMW AG responsible for Production, in San Luis Potosi at an event attended by Mexican President Andres Manuel Lopez Obrador and Governor of San Luis Potosi Ricardo Gallardo Cardona. ShowHide Related Items >><<
|
Syndicate
|
Getaround files to sell 127.42M shares of common stock for holders
17:24 02/03/23 02/0317:24 02/03/2317:24
GETR
Getaround
ShowHide Related Items >><<
|
Syndicate
|
Kiora Pharmaceuticals files to sell 1.05M shares of common stock for holders
17:23 02/03/23 02/0317:23 02/03/2317:23
KPRX
Kiora Pharmaceuticals
ShowHide Related Items >><<
|
Syndicate
|
Durect announces $10M registered direct offering of common stock, warrants »
17:21 02/03/23 02/0317:21 02/03/2317:21
DRRX
Durect
Durect announced that it… Durect announced that it has entered into a definitive agreement with a leading institutional healthcare investor and an existing institutional investor for the purchase and sale of an aggregate of 1,700,000 shares of common stock and, in lieu of shares of common stock, pre-funded warrants to purchase 300,000 shares of common stock, and accompanying warrants to purchase up to 2,000,000 shares of common stock in a registered direct offering. The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.00 per share and accompanying warrant, and the pre-funded warrants are being sold at a combined purchase price of $4.99999 per pre-funded warrant and accompanying warrant. All of the shares of common stock, pre-funded warrants and accompanying warrants to be sold in the Offering will be sold by Durect. The pre-funded warrants have an exercise price of $0.00001 per share and the accompanying warrants will have an exercise price of $5.00 per share. The pre-funded warrants and the accompanying warrants will be immediately exercisable. The pre-funded warrants do not expire and the accompanying warrants will expire five years from the date of issuance. The closing of the Offering is expected to occur on or about February 8, 2023, subject to customary closing conditions. The gross proceeds from the Offering are expected to be approximately $10M, before deducting fees to the placement agents and other estimated offering expenses payable by Durect. Durect intends to use the net proceeds of the Offering for general corporate purposes, which may include clinical trials, research and development activities, capital expenditures, selling, general and administrative costs, facilities expansion, and to meet working capital needs. Cantor Fitzgerald & Co. and Oppenheimer & Co. are acting as lead placement agents for the Offering. ShowHide Related Items >><<
|
Syndicate
|
IO Biotech files $250M mixed securities shelf
17:21 02/03/23 02/0317:21 02/03/2317:21
IOBT
IO Biotech
ShowHide Related Items >><<
|
Conference/Events
|
Activision Blizzard management to meet virtually with Benchmark »
17:08 02/03/23 02/0317:08 02/03/2317:08
ATVI
Activision Blizzard
Virtual Meeting to be… Virtual Meeting to be held with SVP Investor Relations Hickey on February 9 at 12 pm hosted by Benchmark. ShowHide Related Items >><<
|
Syndicate
|
Lilium files to sell 3.1M Class A ordinary shares for holders
17:08 02/03/23 02/0317:08 02/03/2317:08
LILM
Lilium
ShowHide Related Items >><<
|
Syndicate
|
Hempacco files to sell 4.73M shares of common stock »
17:06 02/03/23 02/0317:06 02/03/2317:06
HPCO
Hempacco
The company currently… The company currently estimates that the public offering price will be $1.11 per share. ShowHide Related Items >><<
|
Hot Stocks
|
Forest Road Acquisition Corp. II, HyperloopTT terminate merger agreement »
17:02 02/03/23 02/0317:02 02/03/2317:02
FRXB
Forest Road Acquisition Corp. II
Hyperloop Transportation… Hyperloop Transportation Technologies and Forest Road Acquisition Corp. II have mutually agreed to terminate their previously announced business combination agreement. Considering the significant time to close the business combination, coupled with prevailing market conditions, both parties decided that terminating the agreement is in the best interest of their respective shareholders and employees. |
Syndicate
|
SAB Biotherapeutics files to sell 7.36M shares of common stock for holders
17:02 02/03/23 02/0317:02 02/03/2317:02
SABS
SAB Biotherapeutics
ShowHide Related Items >><<
|
Hot Stocks
|
GAP Airports reports preliminary January passenger traffic up 33.1% »
17:01 02/03/23 02/0317:01 02/03/2317:01
PAC
GAP Airports
For January 2023, the… For January 2023, the total number of terminal passengers at GAP's 12 Mexican airports increased by 30.0%, compared to the same period of 2022. Puerto Vallarta, Los Cabos, Guadalajara, and Tijuana presented an increase in passenger traffic of 46.5%, 39.2%, 31.7%, and 20.1% respectively, compared to January 2022. On the other hand, Montego Bay increase by 67.6% and Kingston 59.6%, compared to 2022. ShowHide Related Items >><<
|